PMID- 31198456 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 1857-9655 (Print) IS - 1857-9655 (Electronic) IS - 1857-9655 (Linking) VI - 7 IP - 9 DP - 2019 May 15 TI - Comparison between the Outcomes of Using Biodegradable-Polymer Drug-Eluting Stents and Those of Using Durable-Polymer Drug-Eluting Stents in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention. PG - 1466-1470 LID - 10.3889/oamjms.2019.345 [doi] AB - BACKGROUND: Many randomised control studies showed that percutaneous coronary interventions using biodegradable-polymer drug-eluting stents (DES) offer a safe and effective alternative to durable-polymer DES. However, not many studies have discussed its use in the setting of acute coronary syndromes. AIM: We aim to compare the biodegradable-polymer DES with durable-polymer DES when it comes to reducing the incidence of non-ST elevation acute coronary syndrome (NSTEACS) associated with adverse events. METHODS: We enrolled 205 patients presenting with NSTEACS and a TIMI risk score >/= 3 in this study and divided them into two groups, group A and group B. Biodegradable-polymer DESs were exclusively used in group A, while durable-polymer DESs were used in group B. Major adverse events were reported in both groups during the hospital stay and patients were followed-up for 1 year. RESULTS: In our patients, we intervened on 390 diseased segments in a total of 360 vessels. After intervention, TIMI 0 was achieved in 0.97%, TIMI 1 in 1.46%, TIMI 2 in 2.45%, and TIMI 3 in 95.12% of the treated segments (P-value= 0.677). We implanted 121 biodegradable-polymer DESs and 146 durable-polymer DESs. Clinical success was achieved in 95.12% of our cases. We had 55 patients who needed repeated coronary angiography within 1 year (15 patients treated with biodegradable-polymer DES and 24 patients treated with durable-polymer DES). Eighteen patients experienced angina pains (8 patients treated with biodegradable-polymer DES and 10 patients treated with durable-polymer DES). Only 5 patients needed TLR (2 patients treated with biodegradable-polymer DES and 3 patients treated with durable -polymer DES) (P-value = 0.591), three of them had a myocardial infarction with documented angiographic evidence of significant in-stent restenosis (1 patient treated with biodegradable-polymer DES and 2 patients treated with durable-polymer DESs). CONCLUSION: Biodegradable-polymer DES represents a comparable alternative to durable-polymer DES in the setting of acute coronary syndromes. FAU - Fawzy, Abd-Allah Y AU - Fawzy AY AD - Critical Care Medicine Department, Cairo University, Cairo, Egypt. FAU - Kenawi, Mahmoud M AU - Kenawi MM AD - Critical Care Medicine Department, Cairo University, Cairo, Egypt. FAU - Aziz, Ahmed Abd El AU - Aziz AAE AD - Critical Care Medicine Department, Cairo University, Cairo, Egypt. FAU - Moharam, Ayman N AU - Moharam AN AD - Critical Care Medicine Department, Cairo University, Cairo, Egypt. FAU - Attia, Ibrahim M AU - Attia IM AD - Critical Care Medicine Department, Cairo University, Cairo, Egypt. LA - eng PT - Journal Article DEP - 20190514 PL - North Macedonia TA - Open Access Maced J Med Sci JT - Open access Macedonian journal of medical sciences JID - 101662294 PMC - PMC6542403 OTO - NOTNLM OT - Acute Coronary Syndrome OT - Biodegradable-Polymer DES OT - Major Adverse Cardiac Events OT - Non-ST Segment Elevation EDAT- 2019/06/15 06:00 MHDA- 2019/06/15 06:01 PMCR- 2019/05/14 CRDT- 2019/06/15 06:00 PHST- 2019/03/04 00:00 [received] PHST- 2019/05/01 00:00 [revised] PHST- 2019/05/02 00:00 [accepted] PHST- 2019/06/15 06:00 [entrez] PHST- 2019/06/15 06:00 [pubmed] PHST- 2019/06/15 06:01 [medline] PHST- 2019/05/14 00:00 [pmc-release] AID - OAMJMS-7-1466 [pii] AID - 10.3889/oamjms.2019.345 [doi] PST - epublish SO - Open Access Maced J Med Sci. 2019 May 14;7(9):1466-1470. doi: 10.3889/oamjms.2019.345. eCollection 2019 May 15.